Amyloid Beta (1-11) Human DAEFRHDSGYE-acid


Segment 1-11 of the beta-amyloid peptide, a key protein in extracellular plaques found in the brains of patients with Alzheimer’s disease

See full description

Catalogue number crb1000080
Sequence (one letter code) DAEFRHDSGYE-acid
Sequence (three letter code) H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-OH
Aliases Abeta1-11
Research Area Neurodegenerative diseases (Alzheimer)
Purity >95%
Storage - 20 ° C
Molecular Weight 1325.3

Masters, C. and Selkoe, D. (2012). Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease. Cold Spring Harb Perspect Med, 2(6), a006262-a006262. PMID: 22675658


Pearson, H. and Peers, C. (2006). Physiological roles for amyloid β peptides. J Physiol, 575(1), 5-10. PMID: 16809372


Selkoe, D. and Hardy, J. (2016). The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med, 8(6), 595-608. PMID: 27025652

Amyloid β-peptide (Aβ) has been identified as the key subunit of the extracellular plaques found in the brains of patients with Alzheimer’s disease (AD) and Down’s syndrome (DS). Aβ has therefore been extensively studied as a potential target for treatment of AD.

Aβ is formed from the cleavage of the large, transmembrane protein; APP (amyloid precursor protein). Cleavage of APP by β- and then γ-secretases results in the formation of Aβ. Aβ can aggregate to produce amyloid-β oligomers, which are thought to be highly neurotoxic. Over time Aβ can further aggregate to produce the characteristic senile plaques present in AD and DS.

Aβ can be degraded by enzymes such as neprilysin, insulin degrading enzyme or endothelin converting enzyme. At physiological levels Aβ may be involved in controlling synaptic activity and neuronal survival.

Amyloid Beta (1-11) Human

Cat No. Pack Size Price Qty


Beta Amyloid (1-11) Human 0.5mg



Beta Amyloid (1-11) Human 1mg